Research suggests that alpha blockers may be linked to an increased risk of fractures in female patients with chronic kidney disease. However, the safety of alpha blockers for blood pressure control in patients on dialysis has also been reported. The relationship between alpha blockers and fracture risk in this patient population is still being explored, with some studies indicating a potential risk and others suggesting the medication may be safe for certain patients.